Clinical Trial

Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia

Study acronym: Shock-V
Recruiting
View on ClinicalTrials.gov →
Summary
Vulvodynia is a chronic vulvar pain condition that can significantly affect quality of life. Low-intensity focal extracorporeal shock wave therapy has been proposed as a non-invasive therapeutic option, but real-world data remain limited. This retrospective observational study aims to evaluate the effectiveness of a four-session focal shock wave therapy protocol in women with vulvodynia treated in routine clinical practice at a university hospital. Clinical data collected during standard care, as well as questionnaire responses, will be analyzed to assess changes in symptoms and functional outcomes following treatment.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-25
Trial Details
NCT Number NCT07553715
Lead Sponsor Nantes University Hospital
Conditions Vulvodynia
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-24